Results

RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/30318577http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/30318577http://www.w3.org/2000/01/rdf-schema#comment"

Objectives

To evaluate endocan levels of patients with polycystic ovary syndrome (PCOS) in comparison to healthy women.

Material and methods

A cross-sectional case-control study on 88 patients with PCOS (mean age, 22.06 ± 4.24 years; body mass index [BMI], 23.9 ± 4.74 kg/m2) and 87 age- and BMI-matched healthy women (mean age, 23.71 ± 4.42 years; BMI, 22.15 ± 3.03 kg/m2).

Results

Serum endocan level was significantly higher in PCOS group than control group (540.9 ± 280.3 pg/mL vs. 355.5 ± 233.5 pg/mL, respectively; p < 0.001). The presence of polycystic ovary finding on ultrasonography or oligomenorhea did not produce significant effect on serum endocan levels (p > 0.05). In PCOS group, endocan level was negatively correlated with BMI and C-reactive protein level, and positively correlated with high density lipoprotein level (p < 0.05).

Conclusions

Blood endocan level is increased in PCOS. Further studies are needed to evaluate the clinical value of blood endocan level as a marker for the risk of cardiovascular and metabolic diseases in patients with PCOS."xsd:string
http://purl.uniprot.org/citations/30318577http://purl.org/dc/terms/identifier"doi:10.5603/gp.a2018.0085"xsd:string
http://purl.uniprot.org/citations/30318577http://purl.uniprot.org/core/author"Laloglu E."xsd:string
http://purl.uniprot.org/citations/30318577http://purl.uniprot.org/core/author"Yapca O.E."xsd:string
http://purl.uniprot.org/citations/30318577http://purl.uniprot.org/core/author"Delibas I.B."xsd:string
http://purl.uniprot.org/citations/30318577http://purl.uniprot.org/core/date"2018"xsd:gYear
http://purl.uniprot.org/citations/30318577http://purl.uniprot.org/core/name"Ginekol Pol"xsd:string
http://purl.uniprot.org/citations/30318577http://purl.uniprot.org/core/pages"500-505"xsd:string
http://purl.uniprot.org/citations/30318577http://purl.uniprot.org/core/title"Does endocan level increase in women with polycystic ovary syndrome? A case - control study."xsd:string
http://purl.uniprot.org/citations/30318577http://purl.uniprot.org/core/volume"89"xsd:string
http://purl.uniprot.org/citations/30318577http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/30318577
http://purl.uniprot.org/citations/30318577http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/30318577
http://purl.uniprot.org/uniprot/#_Q9NQ30-mappedCitation-30318577http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/30318577
http://purl.uniprot.org/uniprot/Q9NQ30http://purl.uniprot.org/core/mappedCitationhttp://purl.uniprot.org/citations/30318577